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Abstract — Mass spectrometry (MS)-based methods have 
become popular in recent years for the quantitation of 
biomolecules, especially peptides and proteins. High Mobility 
Group Box-1 protein (HMGB1) is a nuclear DNA-binding 
protein that resides inside the nucleus and can be released to the 
extracellular space under specific conditions. HMGB1 has been 
reported as circulating mechanistic indicators of cell death mode 
in animal models and in clinical studies. There is accumulating 
evidence that HMGB1 contributes to the pathogenesis of 
inflammatory and autoimmune diseases. Moreover, HMGB1 has 
been found to play an important role in tumor development, 
growth, and spread. Circulating HMGB1 level could be a useful 
and specific marker for evaluating different disease status and 
predicting prognosis in patients. The label-free quantitative 
comparison without any standard reference or normalization of 
the target peptide signal is the simplest Liquid Chromatographic-
MS (LC-MS) method for the quantitation of a protein. The aim 
of the research was the development of an analytical method for 
the quantitation of HMGB1 by a label-free Mass Spectrometry 
technique. In this paper are presented the preliminary results: 
the quantitation of HMGB1 was assessed in a cell lysate sample 
through the use of the standard concentration curve of purified 
HMGB1 protein.  
 
Keywords— Targeted proteomics; shotgun analysis; HMGB1 
quantification. 
I.  INTRODUCTION  
The identification and quantification of proteins is widely 
used in biochemistry. These analyses are mainly performed in 
order to measure changes in protein expression and post-
translational modifications (PTMs) in biological samples. The 
most diffuse proteomic approaches are 2D electrophoresis and 
liquid chromatography (LC-MS): these methods, which 
includes a number of well-established options like MS-based 
methods, coupled to protein (or peptide) separation and 
bioinformatics analysis allow the achievement of protein 
identification and quantification [1]. The identification of 
protein PTMs is very relevant because they can cause 
significant changes of the protein’s physical and chemical 
properties, activity, localization and stability [2]. Biomarkers 
discovery in proteomics is often performed by the use of high-
throughput techniques providing a great number of candidates 
among which the true biomarkers have to be searched for [3].  
There are several methodologies for carrying out the 
quantitation of proteins using both stable isotope labelling or 
label-free workflows [4-8]. Peptides with sequences unique to 
the target protein are usually selected as its surrogates. Peak 
areas of multiple reaction monitoring (MRM) transitions, 
which are the signal created by the peptide fragmentation, are 
integrated as measures of peptide abundance and are used as 
basis for quantitative comparison [9]. During last years, several 
software tools for design and analysis of large scale MRM 
proteomics datasets were developed [10].  
High mobility group box-1 (HMGB1) is a highly conserved 
eukaryotic non-histone chromosomal protein of 215 amino 
acids. HMGB1 has attracted great interest as a prototype for a 
dual-function molecule. Indeed, HMGB1 has highly diverse 
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biological properties that extend from DNA binding to 
transcriptional regulation to chromatin architecture and to 
immune activation. Upon stimulation, HMGB1 undergoes 
translocation from the nucleus to the cytoplasm, and it is then 
secreted in most cells [11]. 
In this work, we developed an analytical method for the 
quantification of HMGB1 proteins using a typical shotgun 
approach: the development of the method includes the sample 
digestion with trypsin and the identification and quantification 
of HMGB1 specific peptides in a complex matrix. 
 
II. EXPERIMENTAL 
A. Sample preparation 
HMGB1 purified protein was used to generate standard 
curves in a complex matrix such a conditioned medium of a 
cancer cell line (sarcomatous malignant mesothelioma MM98 
cell line) [12] spanning from 300 attomoles to 6 femtomoles 
with four concentration levels (7.5, 15, 75 and 150 pg/uL). 
Linear equations for the calibration curves were determined by 
non-weighted linear regression.  
The eukaryotic recombinant HMGB1 protein was produced by 
using the Baculovirus system, and it was purified as previously 
described [13]. MM98 cells were seeded in 100 mm diameter 
plastic dishes with F-10 Ham without serum (Sigma Aldrich, 
Milan, Italy). The conditioned medium (CM) was routinely 
collected, 0.2 µM were filtered, and maintained at -20°C. The 
protein amount of CM, after centrifugation at 300,000 rpm for 
2 h, was determined with Bicinchoninic Acid (BCA) protein 
assay (Sigma Aldrich, Milan, Italy)[12]. After quantification, 
the sample was alkylated and reduced and then overnight 
digested with trypsin (Roche, Basel, Swiss). 
B. Data acquisition 
The data acquisition was performed with a Triple TOF 
5600+ system (AB SCIEX, Concord, ON) equipped with a 
with DuoSpray™ Ion Source. The instrument was coupled to 
an Eksigent micro-LC system (Eksigent, Dublin, CA) with a 
C18 reverse phase column (HALOFused C18, 100 x 0.5 mm, 
Eksigent). Mobile phase A (0.1% (v/v) formic acid in water) 
and B (0.1% (v/v) formic acid in acetonitrile) were used to 
Fig. 1: (a) Chromatogram and peaks intensities traces for three HMGB1 peptides monitored for quantitative analysis. The first peak is from the peptide 
GKPDAAK, the second is from GEHPGLSIGDVAK and the third one is from the peptide HPDASVNFSEFSK which has been used for the quantification; (b) 
MS spectra of the peptide HPDASVNFSEFSK with 488.8956 m/z. 
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create the separation gradient for eluting peptides in the column 
at an increasing concentration of solvent B from 2% to 40 % in 
30 minutes. Data were first acquired in the IDA mode. Peptide 
profiling was performed using a mass range of 350–1250 Da, 
followed by a MS/MS product ion scan from 100 to 1500 Da 
with the abundance threshold set at more than 120 cps. The 
accumulation time for ions was set at 50 ms. Then, samples 
were acquired with Multiple Reaction Monitoring (MRM) 
acquisition mode that provides a wide dynamic range, high 
sensitivity and low measurement variation. The ion source 
parameters in positive turbo ionspray mode were as follows: 
curtain gas 25 psi, GAS1 25 psi, and GAS2 20 psi, ionspray 
voltage 5000 V and source temperature 450ºC. Collision 
energy for each monitored transitions were automatically 
calculated with Skyline software and exported to Analyst 
Software for the data acquisition. The collision energies (CE) 
and declustering potential (DP) used for the analysis of the 
three selected peptides were: CE 22.5 and DP 66.8 for 
HPDASVNFSEFSK, CE 31 and DP 77.8 for 
GEHPGLSIGDVAK and CE 17.3 and DP 56.2 for 
GKPDAAK.   
The Triple TOF combines high resolving power (30k) and 
mass accuracy (<3ppm) with high MS/MS spectral acquisition 
rates (20Hz) that enables a powerful LC-MS/MS discovery 
and quantification platform.  
 
C. Data analysis 
Data analysis was performed using Skyline 1.2 (MacCoss 
Lab Software) and MultiquantTM (ABSciex, Concord, ON, 
Canada) using peptide ion peak areas for quantification and  
PeakViewTM 1.2.0.3 software (ABSciex, Concord, ON, 
Canada).  
III. RESULTS AND DISCUSSION 
The concentration curve with injections from the lowest to 
the highest spike concentrations was acquired and three 
replicates of each point were performed to assess the 
reproducibility of the analysis. The curve for the peptide 
HPDASVNFSEFSK demonstrates an excellent linear response 
with good replicate reproducibility and an R2 of 0.9951. 
Coefficients of variation (CV) were calculated at each 
concentration point across the three replicates: all the CV were 
under 20% (19.75 %, 19.51%, 10.04% and 7.3% from the 
lowest to the highest concentration).  
The limit of detection LOD was 2 pg/µL and has been 
calculated as the concentration of the analyte that gives a signal 
(peak area) equal to the average background (Sblank) plus three 
times the standard deviation of the blank (LOD = Sblank + 
3sblank), while the limit of quantification LOQ is given as LOQ 
= Sblank + 10*sblank and was calculated as 6 pg/µL [14]. 
For the development of the method the free software Skyline 
was used. Figure 1 shows the chromatogram and peaks 
intensities traces (a) for three HMGB1 peptides monitored for 
a 
b  
Fig. 2: (a) MS/MS spectra and (b) SRM traces for the selected transitions of the peptide HPDASVNFSEFSK 
quantitative analysis. The first peak is from the peptide 
GKPDAAK, the second is from GEHPGLSIGDVAK and the 
third one is from the peptide HPDASVNFSEFSK which has 
been used for the quantification. MS spectra of the peptide 
HPDASVNFSEFSK with 488.8956 m/z is shown in figure 1b. 
The selected peptide uniquely identify the targeted protein: 
parallel acquisition of several transitions are used to validate 
the analysis since at the time of peptide elution, such 
transitions yield a perfect set of “co-eluting” intensity peaks 
because derived from the same peptide. Moreover, the 
monitoring of multiple transitions per peptide improves the 
quantitative robustness of the assay. Figure 2 shows the 
MS/MS spectra and the SRM traces for the selected transitions 
of the peptide HPDASVNFSEFSK that was used for the 
quantitation.  
The calibration curve for the selected peptide used for 
quantification of HMGB1 protein is represented in figure 3. 
The calibration curve can be calculated using the sum of the 
area of multiple transitions or exclusively based on MS1 
filtered precursor peak area. Using Multiquant software the 
absolute quantification of HMNGB1 can be carried out in a 
biological sample by comparing the MRM response to the 
standard concentration curve. 
 
IV. CONCLUSIONS 
Many data indicate that HMGB1 might be a diagnostic 
marker, a potent mediator and a therapeutic target in several 
inflammatory, autoimmune and malignant diseases  
However, so far, the detection of HMGB1 is performed by 
time-consuming, semi-quantitative Western blotting. Although 
ELISA approach has been proposed as a convenient way to 
quantify HMGB1 in biological fluids, various molecules have 
been shown to form complexes with HMGB1 and may 
interfere with HMGB1 detection by this technique. So, the 
sensitivity of these methods are limited by several factors 
interfering with the detection and precluding the quantification 
of HMGB1 in biological matrices. The method developed in 
this work is able to quantify HMGB1 proteins using a typical 
shotgun approach: using a specific peptide of HMGB1 its 
quantification at low concentration could be performed. The 
developed technique could be useful in an environment where 
rapid turnaround of protein samples is needed, as well as 
analytical precision. Aside from improving the efficiency and 
speed of the experiments, future efforts will involve 
performing a more complete validation training to demonstrate 
the full bio analytical viability of this approach in different 
complex matrices such as cell lysates and biological fluids and  
the detection’s feasibility off different HMGB1 post-
translational modifications. 
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